Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Jain"


25 mentions found


[1/5] Supporters of the Youth Congress Party hold placards during a silent protest against the conviction of Rahul Gandhi, President of India's main opposition Congress party, in a 2019 Defamation case by a Surat court, on a street in Mumbai, India, March 23, 2023. REUTERS/Francis MascarenhasNEW DELHI, March 24 (Reuters) - Members of India's main opposition Congress party will take to the streets on Friday to protest against leader Rahul Gandhi's conviction for defamation, party officials said a day after a magistrate's court sentenced Gandhi to a two-year jail term. Two senior Congress leaders told Reuters that Gandhi will respect the local court's verdict and will not attend parliament. Officials in the Congress party said they are also depending on regional opposition parties to galvanize political support against the verdict. The president's office confirmed that Congress leaders have sought a meeting with President Draupadi Murmu to lodge a protest against the conviction with the top constitutional executive.
March 24 (Reuters) - Intellectual property services provider IPH Ltd (IPH.AX) said on Friday it has established new network infrastructure and restored key system functionality, a week after reporting a data breach that affected a portion of its IT systems. IPH said on Friday new systems were now in use by the two affected member firms, Spruson & Ferguson (Australia) and Griffith Hack. Sydney-based IPH said it has enhanced network security, adding that it was continuing to work with external cybersecurity and forensic IT advisors on the investigation related to the cyber breach. Fintech firm Latitude Group Holdings (LFS.AX), which also reported a cyberattack last week, had to take its platforms offline after the attack remained active. IPH and Latitude were the latest to join a host of Australian firms which have reported cybersecurity breaches over the past few months.
March 22 (Reuters) - Drug developer 89Bio Inc <ETNB.O> said on Wednesday its experimental treatment for liver disease NASH met the main goals of a small mid-stage study, sending its shares 30% higher. The drug, pegozafermin, helped reduce liver scarring known as fibrosis as measured on two different scales in patients with NASH, or nonalcoholic steatohepatitis, trial data showed. 89Bio said the drug, administered both weekly and every two weeks in the trial, had a safety profile similar to older trials. In the trial, the drug helped significantly reduce fibrosis or liver scarring without the worsening of NASH, compared to a placebo. NASH, a form of non-alcoholic fatty liver disease, is characterized by the organ developing fibrosis or scarring, which can progress to cirrhosis and liver failure.
In November, one of the world's most consequential hedge funds announced a shake-up at the top of its power structure. In an internal memo, the founder of Millennium Management, Izzy Englander, said that Bobby Jain would be vacating the co-CIO role. "You can't readily find that managerial experience at other hedge funds and Goldman is a perfect place to look for those people." 8 former Goldman Sachs leaders are now Millennium execsEnglander isn't alone — firms rarely are in the copycat world of multistrats. In a statement to Insider, Abbey Collins, a spokesperson for Goldman Sachs, said, "Goldman Sachs has always been and remains a talent magnet.
SRINAGAR, March 20 (Reuters) - Indian Kashmir is to get its first foreign investment, with Dubai’s Emaar Group due to build a $60 million shopping and office complex, as the government looks to stabilise a region where Muslim separatists have for years battled the government. The 5 billion rupee ($60.50 million) development will include a shopping mall and multi-purpose commercial tower in Srinagar, the capital of the Muslim-majority Himalayan region, Emaar announced at an investment summit in the city. The announcement on Sunday of what the region's government said was its first foreign investment comes after the central government said last week that Jammu and Kashmir had received record investment of 15 billion rupees ($181 million) in the first 10 months of the 2022-23 (April-March) fiscal year. Emaar Properties (EMAR.DU) CEO Amit Jain told reporters that the investment would have a ripple effect. Nuclear-armed India and Pakistan both claim Kashmir in full but rule in part, and have fought two of their three wars over it.
March 17 (Reuters) - Berkshire Hathaway Inc (BRKa.N), run by billionaire Warren Buffett, on Friday urged shareholders to reject proposals that it avoid discussing hot-button social and political issues, and competing proposals that it disclose more about its climate change and diversity efforts. While Buffett's salary is low, his 15.6% Berkshire stake comprises most of his $101.6 billion net worth, which Forbes magazine said makes him the world's sixth-richest person. Berkshire's more than $60 billion of stock repurchases since the end of 2019 helps preserve Buffett's voting power. Abel would become chief executive and Buffett's son Howard Buffett would become non-executive chairman if Warren Buffett could not continue. Berkshire's businesses include Geico car insurance, the BNSF railroad, Berkshire Hathaway Energy, Dairy Queen, Fruit of the Loom and many others.
In addition to Lantus, Sanofi said it will cut by 70% the list price for its fast-acting insulin, Apidra. The branded list price of Lantus is $438.07 for the pre-filled pens and $292.07 for a 10 ml vial. Rival Novo Nordisk on Tuesday said it would cut U.S. list prices for several insulin products by up to 75% next year. That followed Lilly's March 2 decision to cut list prices by 70% for Humalog and Humulin, its most commonly prescribed insulin products. Most Americans with insurance do not regularly pay list price for insulin, but they may have an insurance co-pay based on the drug's list price or pay full price up to a certain amount of money spent.
March 16 (Reuters) - Sanofi SA (SASY.PA) said on Thursday it would cut U.S. list prices by 78% for its most-prescribed insulin product starting next year, following rivals Novo Nordisk (NOVOb.CO) and Eli Lilly and Co (LLY.N). The move comes as U.S. President Joe Biden has pushed to extend to most Americans the $35 cap on out-of-pocket insulin costs made available to Medicare recipients by the Inflation Reduction Act. Novo Nordisk and Eli Lilly bowed to political pressure earlier this month to make these life-sustaining diabetes treatments more affordable. Reporting by Patrick Wingrove in New York, Pratik Jain in Bengaluru; Editing by Maju SamuelOur Standards: The Thomson Reuters Trust Principles.
In correspondence made public on Tuesday, the SEC's division of corporate finance asked Berkshire to "enhance" its risk management disclosures in its annual proxy filings, and Berkshire agreed to make the requested changes. It also asked Berkshire to address whether its lead independent director can override Buffett on risk matters or ask the board to consider them. The SEC made its requests in a Sept. 2, 2022 letter, and Berkshire Chief Financial Officer Marc Hamburg agreed to them six days later. Berkshire also does not hold analyst calls, and communicates to the public mainly through financial disclosures, its annual meeting and Buffett's annual shareholder letter. He has also said Berkshire's disclosures are sufficient, and many businesses are too small to merit lengthy discussion.
March 14 (Reuters) - Pfizer Inc (PFE.N) said on Tuesday that the U.S. Food and Drug Administration had expanded the emergency use authorization (EUA) of the company and its partner BioNTech SE's (22UAy.DE) bivalent COVID-19 vaccine as a single booster dose in certain children. The amended authorization is for children six months through four years of age who have completed their initial three-dose vaccination with Pfizer's original shot. In December, the U.S. health regulator had authorized Pfizer/BioNTech's updated shot as a third dose to those aged six months through four years, who have not completed their primary vaccination series or are yet to receive the third dose. Shots for youngest children in the United States were only approved in June last year, making them the last group to become eligible for vaccination. Reporting by Pratik Jain; Editing by Maju SamuelOur Standards: The Thomson Reuters Trust Principles.
Pfizer agrees to revise EU COVID vaccine contract -FT
  + stars: | 2023-03-14 | by ( ) www.reuters.com   time to read: +2 min
[1/2] Pfizer company logo is seen at a Pfizer office in Puurs, Belgium, December 2, 2022. Under the revised terms, Pfizer is asking for payment for doses ordered that will never be manufactured, the FT report said. Medzhidiev added that he believed other EU members also would not support the proposed deal in its current form. "The proposed Pfizer amendment to the Pfizer agreement is clearly unacceptable to us given the critical situation of vaccine oversupply in Bulgaria and unjustified financial burden for products destined for destruction," Medzhidiev said. The discussions included the possibility that Pfizer would reduce the up to 500 million COVID-19 vaccine doses the EU has committed to buy this year in return for a higher price.
US VA to cover Eisai, Biogen Alzheimer's treatment Leqembi
  + stars: | 2023-03-14 | by ( ) www.reuters.com   time to read: +1 min
March 13 (Reuters) - Eisai Co Ltd and Biogen Inc (BIIB.O) said on Monday that the U.S. Department of Veteran Affairs (VA) will provide coverage of their Alzheimer's treatment Leqembi to veterans at an early stage of the memory-robbing disease. Leqembi has so far been approved in the U.S. under the Food and Drug Administration's accelerated review program. The treatment is currently undergoing the FDA's standard review process, which will weigh its impact on cognitive function. Eisai and Biogen have said they expect full U.S. approval for Leqembi by summer or late this year, which would likely open up coverage by Medicare and other health insurers. Reporting by Ahmed Aboulenein in Washington and Pratik Jain in Bengaluru; Editing by Bill BerkrotOur Standards: The Thomson Reuters Trust Principles.
NEW DELHI, March 14 (Reuters) - The ideological parent of India's ruling Hindu nationalist Bharatiya Janata Party (BJP) has backed the government position against recognising same-sex marriage, months after raising hopes with supportive comments on gay rights. Prime Minister Narendra Modi's BJP government has opposed recognising same-sex marriage and urged the Supreme Court to reject challenges to the current legal framework lodged by LGBT couples. "Marriage can only take place between persons of opposite genders, we agree with the government's stance on same-sex marriage," the Press Trust of India news agency quoted Dattatreya Hosabale, a top official of the Rashtriya Swayamsevak Sangh (RSS), as saying. Although Bhagwat had not referred specifically to same-sex marriage, his comments could force the government to reassess its opposition, a junior minister in the federal government and a senior BJP leader had said at the time. The RSS, established in 1925, is a powerful Hindu group estimated to have millions of active members across India and overseas.
GQG Partners likely to increase Adani investment, says founder
  + stars: | 2023-03-08 | by ( ) www.reuters.com   time to read: +2 min
SYDNEY, March 8 (Reuters) - GQG Partners would likely expand its investment in the Adani group, the fund firm's founder Rajiv Jain said on Wednesday, a week after its $1.9 billion infusion into the embattled Indian conglomerate. GQG Partners, co-founded by Jain in 2016, bought shares worth $1.87 billion in four Adani group companies, marking the first major investment in the Indian conglomerate since a short-seller's critical report in January sparked a stock rout. Last week, pension fund investor Cbus Super, with A$71 billion ($46.82 billion) under management, told Reuters they had queried GQG about the Adani purchase. A GQG spokesperson said Jain's trip had been planned for some time and the discussions included topics other than Adani. Jain said he has not had a conversation with the Adani group since the transaction.
SYDNEY, March 7 (Reuters) - GQG Partners Inc founder Rajiv Jain will meet clients and investors in Australia this week, the company said in a statement on Tuesday, and will explain its investment into embattled Indian Adani group. GQG Partners bought shares worth $1.87 billion in four Adani group companies, marking the first major investment in the Indian conglomerate since a short-seller's critical report sparked a stock rout. "Rajiv Jain is visiting Australia this week to meet with investors. "It's also an opportunity to respond to any questions they have about the business including the Adani investment." It purchased the stock from the Adani family trust, according to the Indian firm's filings.
BENGALURU, March 7 (Reuters) - Embattled Indian conglomerate Adani Group said it prepaid share-backed financing of 73.74 billion rupees ($901.16 million), as it looks to allay fears over leverage and debt since a U.S. short seller's critical report sparked a stock rout. Promoters of the group's flagship firm, Adani Enterprises (ADEL.NS), will release 31 million shares, or a 4% stake, while Adani Ports' (APSE.NS) promoters will release 155 million shares, or an 11.8% stake, the group said in a statement on Tuesday. Promoters of Adani Green Energy (ADNA.NS) and Adani Transmission (ADAI.NS) will release 1.2% and 4.5% stakes in the respective companies. With Tuesday's repayment, the group has so far repaid around $2.02 billion of share-backed financing, it said. GQG's founder Rajiv Jain will meet clients and investors in Australia this week to explain its investment in the Adani group, the company said in a separate statement on Tuesday.
Sotatercept, combined with a background therapy, helped patients with pulmonary arterial hypertension to walk about 40.8 meters more in six minutes. J.P. Morgan analyst Chris Schott said the data exceeded the brokerage's expectations and "should confirm the drug as go-to add-on therapy" for pulmonary arterial hypertension. Schott forecast peak sales of $3 billion to $4 billion for the drug. In October, Merck said sotatercept had met the main goal of a late-stage study, but did not release the full data. Reporting by Khushi Mandowara and Pratik Jain in Bengaluru; Editing by Arun Koyyur and Shinjini GanguliOur Standards: The Thomson Reuters Trust Principles.
Chairperson of Indian conglomerate Adani Group, Gautam Adani, speaks at the World Congress of Accountants in Mumbai on November 19, 2022. Indranil Mukherjee | AFP | Getty ImagesIndia's embattled industrialist Gautam Adani received a much-needed vote of confidence from a well-respected U.S. asset manager ahead of a crucial bond roadshow that's underway. "Controversy is part of how you get better returns," Jain told CNBC in an exclusive interview. Jain's investment follows a massive decline in Adani's stock price amid criticism of the Indian firm's practices. Shares of Adani Enterprises and Adani Ports are up 66% and 23% over the past seven days, respectively.
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailGQG Partners' CIO Rajiv Jain on his Adani Group investment thesisSeema Mody speaks to GQG Partners CIO Rajiv Jain, who is betting on the embattled Indian industrialist Gautam Adani with a $1.9B investment.
SYDNEY/BENGALURU, March 3 (Reuters) - Adani shares surged on Friday after a $1.87 billion investment in the group by GQG Partners Inc eased concerns about the group's ability to attract funding, while the conglomerate lined up more road shows to shore up investor confidence. Adani Group will hold road shows this month in London, Dubai and several cities in the United States, according to a document seen by Reuters. Overall, Adani group firms' net debt totalled $24.1 billion as of September 2022. Adani Green Energy and Adani Transmission jumped 5% each. Dollar bonds issued by Adani entities also rallied, with Adani Green Energy's 2024 bond adding 2.3 cents on the dollar to trade at 85.5 cents, while most bonds issued by Adani Ports and Special Economic Zone, Adani Transmission and Adani Electricity Mumbai rose by more than 1 cent.
Adani shares soar as US investor steps in
  + stars: | 2023-03-03 | by ( Anna Cooban | ) edition.cnn.com   time to read: +2 min
London CNN —Shares in some of Indian billionaire Gautam Adani’s companies soared Friday after a US private equity firm agreed to invest nearly $1.9 billion in his embattled conglomerate. The Adani Group said Thursday that GQG Partners had bought $1.87 billion of stock in secondary market trades across four of its companies. Shares of the group’s flagship company, Adani Enterprises, soared nearly 17% following the announcement. Shares of Adani Ports rose almost 10%, while Adani Green Energy and Adani Transmission both gained 5%. And Australia-listed GQG Partners, which manages more than $92 billion in assets, doesn’t appear to share the concerns of other investors.
Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailConsumers are still 'cost-cautious' as inflation persists, analyst saysShikha Jain, partner at Simon-Kucher & Partners, discusses the latest from the U.S. retail earnings season.
Adani contrarian is a win for Hindenburg, too
  + stars: | 2023-03-03 | by ( Una Galani | ) www.reuters.com   time to read: +6 min
GQG Partners is snapping up shares in four of the Indian tycoon’s nine core companies, including the flagship Adani Enterprises (ADEL.NS), along with Adani Green Energy (ADNA.NS), Adani Ports and Special Economic Zone (APSE.NS) and Adani Transmission (ADAI.NS). The mogul was trying to do just that last month with a $2.5 billion Adani Enterprise share sale before it was scuppered by Hindenburg’s sortie. Barring something truly exceptional, the scars of Hindenburg’s successful attack on Adani will linger for a while. GQG bought shares in Adani Ports and Special Economic Zone, Adani Green Energy, Adani Transmission and Adani Enterprises from entities owned by the Adani family. Adani has dismissed the allegations outlined in U.S. fund Hindenburg Research’s Jan. 24 report.
BENGALURU, March 2 (Reuters) - U.S. boutique investment firm GQG Partners has bought shares worth $1.87 billion in four Adani group companies, marking the first major investment in the Indian conglomerate since a short-seller's critical report sparked a stock rout. U.S-based, Australia-listed GQG has, through block deals, bought shares worth 154.46 billion rupees in four Adani group companies, including the conglomerate's flagship firm Adani Enterprises (ADEL.NS), a regulatory filing showed. GQG took a 3.4% stake in Adani Enterprises for about $662 million, 4.1% in Adani Ports for $640 million, 2.5% in Adani Transmission for $230 million, and a 3.5% stake in Adani Green Energy for $340 million. "This transaction marks the continued confidence of global investors in the governance, management practices and the growth of Adani Portfolio of companies," said Adani Group CFO Jugeshinder Singh. In the run-up to the announcement, Adani group shares rallied, with Adani Enterprises climbing nearly 35% over the last three sessions, Adani Ports 11% and Adani Green Energy 16%.
The VanEck Digital India ETF is the only India-focused stock exchange-traded fund listed on Western exchanges to have posted gains this year. The emerging market fund tracks the MVIS Digital India Index. "We suspect this will remain the dominant theme setting the direction for Indian markets in the near term." However, the short-term turmoil in Indian markets hasn't upset long-term bulls on the Indian economy, according to Dutch bank ING. CNBC Pro did not include the Canada-listed iShares India Index ETF and BMO MSCI India ESG Leaders Index ETF and U.S.-listed VanEck India Growth Leaders ETF owing to a lack of price targets from FactSet.
Total: 25